LIGAND PHARMACEUTICALS INCORPORATED
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $49.6M | $11.6M |
| FY2014 | — | $26.3M | $160.2M |
| FY2015 | — | $237.3M | $97.4M |
| FY2016 | — | $341.3M | $18.8M |
| FY2017 | — | $399.8M | $20.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $49.6M | $11.6M |
| FY2014 | — | $26.3M | $160.2M |
| FY2015 | — | $237.3M | $97.4M |
| FY2016 | — | $341.3M | $18.8M |
| FY2017 | — | $399.8M | $20.6M |